PXN, paxillin, 5829

N. diseases: 116; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 AlteredExpression disease BEFREE The present study aimed to assess FAK/Src/PXN protein expression in both primary and liver metastatic sites of colorectal adenocarcinoma (CRC). 29135089 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 AlteredExpression disease BEFREE A number of cancers show increased expression of paxillin which plays a central role in tumor progression, including colorectal cancer. 25973017 2015
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 Biomarker disease BEFREE We thus hypothesized that pPXN-Y31/Y118 may be required for Bcl-2 protein stability via PXN interacting with Bcl-2 to confer 5-FU resistance in colorectal cancer. 25323586 2015
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 AlteredExpression disease BEFREE Paxillin was expressed at significantly higher levels in colorectal cancer tissues and might serve as a potential prognostic indicator in patients with colorectal cancer. 26159303 2015
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 AlteredExpression disease BEFREE Immunohistochemistry staining was used to assess the expression of paxillin and its association with the expression of carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, p53 and Bcl-2 in 102 patients with primary colorectal carcinoma. 24451945 2014
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 AlteredExpression disease BEFREE The use of miR-137 mimics or inhibitor could decrease or increase PXN mRNA and protein levels in CRC cell lines. 23275153 2013
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 PosttranslationalModification disease BEFREE Here, we show that paxillin is a direct substrate of PTPRT and that PTPRT specifically regulates paxillin phosphorylation at tyrosine residue 88 (Y88) in colorectal cancer (CRC) cells. 20133777 2010
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.080 Biomarker disease BEFREE The purpose of the present study was to determine the effects of G17 amide on tyrosine phosphorylation of focal adhesion kinase (FAK), paxillin, and p130 Crk-associated substrate (p130(Cas)) in Colo 320 cells, a human colorectal cancer cell line which expresses CCK(2) receptors. 14667936 2004